Alexandria, Va. - Jan. 24, 2013 Seniors have serious concerns regarding mandatory mail order pharmacy requirements in prescription drug plans, according to a new national survey of 669 Medicare Part D beneficiaries released today by the National Community Pharmacists Association (NCPA).
Nearly two-thirds of seniors (63 percent) indicated they were fearful of losing access to the pharmacy of their choice if they were required to use mail order. In addition, a plurality of seniors expressed concerns about using mail order pharmacies, including running out of their medications; obtaining prescriptions in a timely manner; lost, stolen or damaged medications; and the ability to consult with a pharmacist they know and trust.
"Mail order is not for everyone. In fact, consumers have said that it's not for most people. Patients deserve a choice and they don't like being told which pharmacy they have to use," said NCPA CEO B. Douglas Hoey, RPh, MBA. "The findings of this survey should be a significant red flag for policymakers. First, policymakers should oppose requirements or further inducements to steer patients to mail order pharmacies against their preference. Second, employers and other sponsors of private health plans that require the use of mail order should reconsider their prescription drug plan's design."
Hoey continued "denying seniors, many of whom are on complex medication regimens, the right to obtain medication from the pharmacy of their choice and from a pharmacist they trust deprives them of vital face-to-face consultation with one of their healthcare providers. Local pharmacists help to reduce medication waste that may be associated with mail order, auto-ship programs. They also provide services unique to the community such as offering same day home delivery or fulfilling patient-specific requests. These services not only benefit the patient, they benefit the healthcare system by reducing the number of preventable, bad outcomes that often lead to costly hospitalizations or emergency room visits that drive up healthcare costs."
Other key findings from the survey responses include:
About one-third of respondents (35 percent) submitted handwritten comments in addition to their completed surveys, and 82.7 percent of these comments contained one or more concerns and/or negative attitudes toward mail order pharmacy. Comments included the following:
The findings of this survey echo those of other recent surveys. The J.D. Power and Associates 2012 U.S. Pharmacy Study showed satisfaction among mail order customers to be declining and significantly lower than customers of brick and mortar pharmacies. A 2012 Walgreens survey found that four out of five patients prefer to obtain their medications at a retail pharmacy over mail order. Some common patient complaints about mandatory mail order were portrayed in an online video entitled "Mail Order Madness" that has garnered thousands of views on YouTube.
Public sentiment is clearly against mandatory mail order plans. In recent years New York and Pennsylvania enacted laws giving many patients the ability to transfer prescriptions from mail order to a local pharmacy that agrees to accept the same pricing terms and conditions. NCPA will continue to advocate for prescription plan designs that offer patients a choice in pharmacy and that allow patients to select pharmacy providers that best suit their individual needs.
About the Survey: The survey was conducted by MENTORx on behalf of the National Community Pharmacists Association to survey the attitudes of Medicare-eligible Americans toward the implementation of mandatory mail-order pharmacy services in their prescription benefit plans. The survey was mailed to a random sample of 6,500 Medicare beneficiaries and results are based on the 669 completed surveys returned during the data collection period of November-December 2012. The average age for respondents was 72.4 with women submitting 57% of the completed surveys. Overall, the returned surveys represent 644 ZIP codes in 43 states.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs